Search clinical trials for: Calcineurin Inhibitors

Total 64216 results

University of Cincinnati
University of Colorado, Denver; Children's Hospital Medical Center, Cincinnati

Completed

Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients

Complication of Transplant

United States
Chinese University of Hong Kong

Completed

Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis

Lupus Erythematosus, Systemic | Lupus Nephritis

Hong Kong
Astellas Pharma Inc

Completed

Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients

Ulcerative Colitis

Japan
Astellas Pharma Inc

Completed

Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

Lupus Nephritis

Japan
Chiesi Hungary Ltd.
Chiesi Slovenija, d.o.o.

Recruiting

Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients (LTA)

Liver Failure

Hungary, Slovenia
UNC Lineberger Comprehensive Cancer Center
University of North Carolina, Chapel Hill

Completed

Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Acute GVHD

United States
Seoul National University Hospital
Chong Kun Dang Pharmaceutical

Completed

Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children

Nephrotic Syndrome

Korea, Republic of
Pontificia Universidad Catolica de Chile

Completed

Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors (FKosl)

Evidence of Liver Transplantation | Effects of Immunosuppressant Therapy

Chile
Seoul National University Hospital

Completed

Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome (MCNS)

Minimal Change Disease

Korea, Republic of
Maastricht University Medical Center

Unknown

Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patients

Organ Transplantation

Netherlands
University of North Carolina, Chapel Hill

Completed

Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients (TAC3A5)

Renal Transplant

United States
University of Colorado, Denver

Completed

CNS Study of Patients Switching From Tacrolimus to Envarsus

Renal Transplant Patients

United States
Weill Medical College of Cornell University

Terminated

Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status (TIMELY)

Immunosuppression

United States
Sun Yat-sen University

Completed

Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)

Kidney Diseases | Nephrotic Syndrome | Tacrolimus
Astellas Pharma Inc

Completed

A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients

Transplantation

Netherlands, Spain, Germany, United Kingdom, Poland, France
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

Psoriasis

United States, Canada
Heinrich-Heine University, Duesseldorf

Completed

Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)

Cutaneous Lupus Erythematosus

Germany
Université de Sherbrooke
McMaster University

Recruiting

Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY) (CINERGY)

Ischemic Reperfusion Injury | Brain Death | Organ Transplant Failure or Rejection

Canada
Roberto Gedaly
Veloxis Pharmaceuticals

Recruiting

Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

End Stage Renal Disease

United States
Barts & The London NHS Trust

Withdrawn

ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT (ENTREAT)

Renal Transplant Failure

United Kingdom
University of Kansas Medical Center
Veloxis Pharmaceuticals

Completed

Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Immediate Release Tacrolimus to Slow Release Envarsus

End Stage Renal Disease

United States
Astellas Pharma Europe Ltd.

Completed

A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant (ADDRESS)

Liver Transplant | Kidney Transplant

Italy, Spain, Belgium, Germany, Latvia, Canada, Korea, Republic of, Czechia, Austria, Finland, Belarus, Estonia, France, Hungary, Ireland, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Sweden, Switzerland, United...
Astellas Pharma China, Inc.

Completed

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

Moderate/Severe Atopic Dermatitis

China
Astellas Pharma Inc

Completed

Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis

Keratoconjunctivitis | Conjunctivitis

Japan
The Second Hospital of Tangshan
Chinese PLA General Hospital

Recruiting

Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patients

Liver Transplantation | Chronic Pain

China
West China Hospital

Recruiting

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma

China
Odense University Hospital

Active, not recruiting

Prevention of Breast Cancer-related Lymphedma With Tacrolimus (BCRL-TACRO)

Lymphedema

Denmark
University of Manitoba

Completed

Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver Transplants

Liver Failure

Canada
Peking Union Medical College Hospital

Unknown

Tacrolimus Treatment for Refractory Autoimmune Cytopenia

Pure Red Cell Aplasia | Autoimmune Hemolytic Anemia | Evans Syndrome

China
The Eye Center and The Eye Foundation for Research...

Unknown

Ocular Penetration of Topical Tacrolimus Eye Drops

Ocular Penetration of Topical Tacrolimus

Saudi Arabia
Veloxis Pharmaceuticals

Approved for marketing

Expanded Access Study for Renal Transplant Patients With Envarsus XR ™

Renal Failure
Nanjing University School of Medicine

Withdrawn

Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis

Focal Glomerulosclerosis

China
Oslo University Hospital

Completed

Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo

Vitiligo
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

Psoriasis

United States, Canada
Qianfoshan Hospital

Not yet recruiting

Prognostic Model of TAC in the Treatment of MN

Idiopathic Membranous Nephropathy
University Health Network, Toronto
Paladin Labs Inc.

Not yet recruiting

Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients

Liver Transplant Rejection | Immune System Suppression
TFF Pharmaceuticals, Inc.

Recruiting

An Open Label Trial Evaluating Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients

Lung Transplant Rejection

Australia
University of California, Davis
Veloxis Pharmaceuticals

Completed

A Pilot Study to Evaluate Impact on Neurological Side Effects (Cognition, Memory, and Tremor) in Elderly (Age>65) Patients

Toxicity | Neurotoxicity | Kidney Transplant; Complications | Drug Toxicity

United States
University of Wisconsin, Madison
Veloxis Pharmaceuticals

Completed

Envarsus in Delayed Graft Function (E-DGF) (E-DGF)

Delayed Graft Function

United States
University Hospital, Bordeaux

Completed

Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC (VITAC)

Vitiligo

France
Linical Korea
Asan Medical Center

Completed

Evaluate the Efficacy and Safety of the ADVAGRAF® (STABLE)

Evidence of Liver Transplantation

Korea, Republic of
Assistance Publique - Hôpitaux de Paris
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Unknown

Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant Patients (TACTHEP)

Liver Transplantation, Child

France
Astellas Pharma Korea, Inc.

Terminated

A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients (APPLE)

Lupus Nephritis

Korea, Republic of
Astellas Pharma Inc
Astellas Pharma Korea, Inc.

Completed

A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs) (TREASURE)

Rheumatoid Arthritis

Korea, Republic of
Peking Union Medical College Hospital

Unknown

Tacrolimus Treatment for Refractory PRCA

Pure Red Cell Aplasia

China
University of Aberdeen

Completed

Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease

Crohn Disease

United Kingdom
Astellas Pharma Inc

Completed

An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Myasthenia Gravis

Japan
Ultragenyx Pharmaceutical Inc

Active, not recruiting

Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta (Cosmic)

Osteogenesis Imperfecta

United States, Italy, Brazil, France, Canada, Germany, Netherlands, Poland
University Hospital, Essen

Recruiting

Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation (Pro-Tac)

Pediatric Kidney Disease

Germany
Imperial College London

Recruiting

Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation (EVITRA)

Immunosuppression | Kidney Transplant Failure | Allosensitization

United Kingdom

Search clinical trials for: Calcineurin Inhibitors

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations